ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

DEST Destiny Pharma Plc

16.25
-0.50 (-2.99%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Destiny Pharma Plc LSE:DEST London Ordinary Share GB00BDHSP575 ORD GBP0.01
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.50 -2.99% 16.25 16.00 16.50 16.75 15.00 16.75 1,536,814 16:04:28
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -6.5M -0.0683 -2.38 15.48M
Destiny Pharma Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker DEST. The last closing price for Destiny Pharma was 16.75p. Over the last year, Destiny Pharma shares have traded in a share price range of 13.50p to 83.00p.

Destiny Pharma currently has 95,271,863 shares in issue. The market capitalisation of Destiny Pharma is £15.48 million. Destiny Pharma has a price to earnings ratio (PE ratio) of -2.38.

Destiny Pharma Share Discussion Threads

Showing 2651 to 2675 of 2900 messages
Chat Pages: 116  115  114  113  112  111  110  109  108  107  106  105  Older
DateSubjectAuthorDiscuss
05/2/2024
09:14
Do you not think Hoping about news coming soon caused the rises John ?
arab3
05/2/2024
09:11
well i took some @ 38p

Hopefully XF73 news not to far away.

john henry
05/2/2024
08:33
Well its hit 2nd target support @ 39p FIB 76.4% retrace.

I must admit thats some hit.

Next Horizontal support potentially 35p before a possible technical rebound. Daily RSI 18

35p is the price of the fund raise 12 months ago and the announcement of the Sebela JV

38M wiped off the market cap so far. MKT Cap now £36M

Aimho

john henry
05/2/2024
06:14
Not much support for the share price . Gap to fill at 30p and unlikely any news to stop the rot . The mms will also want to trigger stops losses on spread bets etc and rake in the money on the way down . Awful markets but companies have to deliver and move faster in a very slow sector otherwise it's downwards
bones698
04/2/2024
20:09
Very true.
Put your money where your mouth is.
Still holding , topped up Friday.
Hoping this will recover tomorrow.
Soon see.
GLA

mam fach
04/2/2024
18:19
you were one of the biggest hypers mam fach ,you did say the only way is up a couple of weeks back
a lot of hope required here now

arab3
04/2/2024
17:13
All tipsters the same. Buy before they Tip then sell before they advise stop loss.
Had all this hype about new CEO yet no apparent progress in negotiations.
What a surprise it would be to get amazing news.
DEST do have amazing products in the pipeline.
Hoping price will start to recover from Monday.
GLA

mam fach
03/2/2024
08:04
These critical findings support the urgency of XF-73 nasal's late-stage development and need for its global regulatory approval.

IMHO note this sentence.

XF73 Dermal now clinically enabled. Pipeline continues to grow in value.

john henry
03/2/2024
08:02
These critical findings support the urgency of XF-73 nasal's late-stage development and need for its global regulatory approval. XF--73 demonstrates exceptionally broad potency across a huge range of Staphylococcus isolates, including antibiotic resistant strains, with no resistance observed. This study demonstrates XF-73's global effectiveness and reinforces the significant commercial opportunity. Importantly it also demonstrates the potential of XF-73 nasal to address the shortcomings of current standard of care nasal antibiotics, which contribute to the global rise in Staphylococcus aureus antibiotic resistance thereby limiting the effectiveness of current infection reduction approaches.

Dr Bill Love, Chief Scientific Officer of Destiny Pharma said: "This peer-reviewed publication demonstrates that XF-73 has activity against all global staphylococcal strains tested that were obtained from patients who had infection from these bacteria. This landmark data set will support the approval process for this breakthrough drug in our lead indication for the prevention of postsurgical staphylococcal infection."

Chris Tovey, CEO of Destiny Pharma, added: "The World Health Organisation has declared antimicrobial resistance to be one of the top ten global public health threats facing humanity. These new findings underscore the transformative potential of XF-73 nasal not only to prevent post-surgical infection of a vast range of staphylococcal strains but also, critically, to be effective against all S. aureus tested antibiotic resistant strains. We look forward to sharing further details on the importance of these findings at our XF pipeline event later today."

john henry
03/2/2024
07:54
arab3 There has been a large seller dripping stock into the market on a daily basis for Months.
The volume over the past 3 days maybe them clearing out completely, taking advantage of the volume.
6M shares traded, 3M on the buy side 3M on the sell side.

AIMHO

john henry
03/2/2024
07:47
TTLANCE can you explain the reasoning behind your statement.

Worth noting they are in discussions with a number of potential partners.

And after 16 months probably fairly close to conducting a JV.



The outstanding data released nearly 4 months ago would have attracted even more interest

Aimho

john henry
02/2/2024
22:17
This will continue to drift lower with no positive news likely. The only thing that give the price some support is XF-73 and with partnership negotiations been ongoing now for 16 months, things aren’t looking encouraging for a large upfront payment.
ttlance
02/2/2024
22:05
but what price will it be at when they are out ?
arab3
02/2/2024
21:48
82k and a 54k dumped earlier doors yesterday.
No wonder Dest is getting hit hard, someone is dumping stock big time.
Price could rebound strong once they are out.
Nearly 6M traded the last few days

john henry
02/2/2024
21:36
Yes his pumping has worked well for HIM. No I in Team.
oapknob1
02/2/2024
20:23
To be fair to JW he quite rightly put a stop loss in at a level that was its resistance. Like every stock, you can be positive about it but that doesn’t mean you know the direction the price will take or its outcome. The approach of psychologically thinking you are 100% invested into a winner is very dangerous. Investors have this approach when they experience positive affirmation's from prior or existing investments, thinking you have nailed the stock market. His approach is called risk management and its worked well for him.
ttlance
02/2/2024
20:01
Turning into another JW sharepickers pump n dump like POLX.
oapknob1
02/2/2024
19:38
Amazing how sentiment has changed here. Only 2 weeks ago there was massive optimism, lording TC and highlighting how XF-73 was going to change the infection market. Investors have been truly suckered into this stock. Investors enjoying the share price rise in the last 9 months have put their own narrative to this, thinking it was a one way bet.
ttlance
02/2/2024
18:54
Technically DEST is in the MUD
john henry
02/2/2024
18:34
Agree but we will have to wait and see
xcap1
02/2/2024
18:14
there is a gap to fill at 30p . I suspect it will head towards that unless something unexpected happens :(
jeanesy
02/2/2024
18:05
I see 3 areas of possible support.Horizontal 1 42.5p Horizontal 2 36pFib 76.4 retrace 39p
john henry
02/2/2024
17:56
They did Weds
john henry
02/2/2024
17:54
Wade family own 6.21% it’s just split into jemima and the furniture company but she owns the furniture company
brooko19
02/2/2024
17:34
The silence from the company is deafening . They have to say something surely !
jeanesy
Chat Pages: 116  115  114  113  112  111  110  109  108  107  106  105  Older

Your Recent History

Delayed Upgrade Clock